We are down to the wire for Tuesday’s (April 22) What’s Hot in Cancer Immunotherapy event. The star-studded lineup features leading executives, scientists, entrepreneurs, and investors—from Seattle and beyond, and from both biotechs and pharma. They all convene starting at 2:45 pm tomorrow, Tuesday, April 22, at the Fred Hutchinson Cancer Research Center.
It is shaping up as one of Seattle’s most illuminating and important life sciences events of the year.
The event was organized by former Xconomy National Biotech Editor Luke Timmerman, who will be on hand to emcee the show. The afternoon promises to be insightful and fast-moving—the three-hour program ends at 5:45 pm, with plenty of time for networking afterward.
There are just seven tickets left as of Monday morning, so grab them fast and find more details here.
Here are the speakers once again:
Hans Bishop, CEO, Juno Therapeutics
Teresa Foy, CSO, Oncofactor Corporation
Mitch Gold, Executive Chairman, Alpine BioSciences
Rob Hershberg, CEO, VentiRx Pharmaceuticals
Deborah Law, VP, Biologics Discovery, Merck
Ira Mellman, VP, Cancer Immunology, Genentech
Robert Nelsen, Managing Director, Arch Venture Partners
Martin Oft, VP, Clinical and Regulatory Affairs, ARMO BioSciences
Stan Riddell, Researcher, Fred Hutchinson Cancer Research Center
Chad Robins, CEO, Adaptive Biotechnologies